Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Sep;94(3):895-901.
doi: 10.1016/j.athoracsur.2012.04.091. Epub 2012 Jul 25.

Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer

Anthony W Kim  1 , Frank C Detterbeck, Daniel J Boffa, Roy H Decker, Pamela R Soulos, Laura D Cramer, Cary P Gross
Affiliations
Comparative Study

Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer

Anthony W Kim et al. Ann Thorac Surg. 2012 Sep.

Abstract

Background: Racial disparities in access to surgical resection for treatment of early-stage non-small-cell lung cancer (NSCLC) are well documented. However it is unclear how race, clinical, and hospital characteristics affect the surgical approach among patients undergoing resection.

Methods: Using the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER)/Medicare linked database, we identified patients 67 years of age or older diagnosed with stage I NSCLC who underwent surgical resection from 2000 to 2007. Surgical approach was categorized as lobectomy or segmentectomy (anatomic) versus wedge resection (nonanatomic). We used logistic regression to identify the association between demographic, clinical, and hospital factors and the use of nonanatomic resections.

Results: There were 8,986 patients in the sample (mean age, 75 years; 53% women); 12.8% underwent nonanatomic resection. The use of nonanatomic resection increased significantly, from 11.0% in 2000 to 15.9% in 2007 (p=0.008). In multivariable analysis, race was not associated with the receipt of nonanatomic resection. Factors associated with the use of nonanatomic resections included age greater than 80 years (odds ratio [OR], 1.51; 95% confidence interval [CI], 1.15-1.98), T1a primary tumor status, chronic obstructive pulmonary disease (COPD) (OR, 1.81; 95% CI, 1.55-2.12), and volume of hospital lung resections performed (highest versus lowest hospital volume, OR, 1.58; 95% CI, 1.23-2.04). More nonanatomic resections were performed in 2007 than in 2000 (OR, 1.73; 95% CI, 1.27-2.37). After stratifying by tumor size, the temporal trend in the use of nonanatomic resection remained significant only among patients with tumors greater than 3 cm.

Conclusions: Since 2000, the use of nonanatomic resections in stage I NSCLC has increased, most significantly among patients with larger tumors. After adjusting for clinical factors, there was no relation between race and type of surgical resection.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Frequency of nonanatomic resections from 2000 to 2007 grouped according to size of the primary tumor.
Fig. 2
Fig. 2
Adjusted odds ratios for receipt of nonanatomic resection according to quintiles of hospital volume. The first quintile is the reference quintile.
Fig. 3
Fig. 3
Use of nonanatomic resection according to tumor size and chronic obstructive pulmonary disease (COPD) status.
See this image and copyright information in PMC

References

    1. El-Sherif A, Gooding WE, Santos R, et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg. 2006;82:408–415. discussion 415– 6. - PubMed
    1. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–622. discussion 622–3. - PubMed
    1. National Cancer Comprehensive Network. [Accessed May 7, 2012];NCCN Guidelines. Non–small-cell lung cancer. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
    1. Scott WJ, Howington J, Feigenberg S, et al. Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition) Chest. 2007;132:234S–242S. - PubMed
    1. Bach PB, Guadagnoli E, Schrag D, et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002;40:IV–19–IV–25. - PubMed

Publication types

MeSH terms